Alterations of choline phospholipid metabolism in ovarian tumor progression.
about
Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatmentRegulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cellsIn vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian CancerCholine Metabolism Alteration: A Focus on Ovarian CancerMolecular magnetic resonance imaging in cancerCholine metabolism-based molecular diagnosis of cancer: an updateCrystal Structures of Human Choline Kinase Isoforms in Complex with Hemicholinium-3: SINGLE AMINO ACID NEAR THE ACTIVE SITE INFLUENCES INHIBITOR SENSITIVITYKey Players in Choline Metabolic Reprograming in Triple-Negative Breast CancerCholine kinase and its functionHDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cellsCholine-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasisSilencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products.Effect of Pantethine on Ovarian Tumor Progression and Choline Metabolism.Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells.Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells.Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.Comparative metabolomic analysis of HPAC cells following the acquisition of erlotinib resistanceHyperpolarized (13)C spectroscopy and an NMR-compatible bioreactor system for the investigation of real-time cellular metabolism.Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.Differentiation of benign and malignant uterine corpus tumors by using proton MR spectroscopy at 3T: preliminary study.Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models.Mycobacterial heat shock protein 65 mediated metabolic shift in decidualization of human endometrial stromal cellsMetabolomics Identifies Metabolic Markers of Maturation in Human Pluripotent Stem Cell-Derived Cardiomyocytes.Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples.Cholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometryMagnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancerGlycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancerOxidative species and S-glutathionyl conjugates in the apoptosis induction by allyl thiosulfate.Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition.A joint analysis of metabolomics and genetics of breast cancer.Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanineCombined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.Metabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR Spectroscopy17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signalingNoninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cellsCholine kinase inhibition in rheumatoid arthritis.
P2860
Q24317541-E694805F-8003-48CB-A527-C87D22945448Q24646815-3584EFD6-6B3F-4D14-B1E4-99F46761D4CCQ26742109-7CC95061-9E6E-4AC7-A5CF-2888A8757834Q26742116-12F8C1B9-7F9A-4F84-870C-98D6446682B2Q26782151-C0115667-6011-4B12-88A8-ACAB3BB95161Q27024079-0449E135-4B72-4D00-8682-ED9017B74E81Q27660277-4093BC06-B0EA-476B-B592-AFD2DA5BD835Q28074613-14BA4EE3-A583-4D4B-AC3D-43B3B64308FEQ28288614-2FA21823-F854-4D74-A3B3-AAD1EBB3F4E9Q28486529-82D99E32-4C51-4736-BD66-9B9B39E2E258Q30514230-0E1E38E9-1FB3-4426-9252-80D87A6D1214Q30808489-2C9F6C86-C3D1-44E9-BE5C-39924EF02AF8Q30874197-6C8E9ECA-6AC3-44C0-9BAD-DA967E38E63FQ31145516-EAA7A6AC-BCEF-4581-A7F5-9EF5D02487B4Q33576337-B0F3DAC3-B94F-4A0E-A648-237E15F560ABQ33580152-176C2D32-F5C6-43DC-A1C0-460CB0211372Q33631482-20ABB535-712B-424D-A318-5DF13F0187DAQ33686090-6ACFB590-4B76-430C-ADCF-C912E48C48E3Q33690907-7221C3E1-F28A-4334-8641-3F1593813718Q33699139-FE86DAE7-954C-4389-94AE-19AE0DC7FE51Q33709001-48BFA681-D21D-47B0-88E4-F19B59D65DD9Q33736511-3293BA3D-C358-44B7-8EB5-0D510666DAB3Q33822437-027F6C0F-1249-4A5F-B840-DD300596B5A7Q33836433-558264E8-670C-4C1B-AC25-5D47C93B3632Q33842777-97F2F2BB-A63A-41BE-8C2A-C85E63AEC295Q33844930-B7631543-F816-47B3-A8CE-6321866A783FQ33858266-8404E2A7-E0F0-41D5-8F92-7B0186B726C4Q33881902-381D6DF0-478F-491C-981F-713EA6C21D73Q34020037-C24AA4DF-7096-4DF8-92B1-3AD54CEFB753Q34060934-BCEDCE1A-BBFB-4C98-B78B-23947F926857Q34201606-951E5FC7-97A3-4A31-AEF7-B7300E6BFE14Q34249948-4E166430-FE95-4567-8738-6BDD2119427CQ34296486-17EA4EF2-EEB1-4E0C-B5B9-BB8323924151Q34407085-0A99E460-7ADF-442F-A2BF-090018818926Q34769536-8E8276B3-647A-4053-8769-ED2216B43390Q34960082-910D6851-582E-4445-A161-5C62B458E21EQ34989144-84EA0D95-3424-490E-863B-19E97BC6E93CQ35106366-10678200-D898-480B-8F84-7B056786C4EBQ35112020-97A8B64C-CF41-4D9D-9404-9A2AC1EE111AQ35243831-482885C8-9EA4-4BED-87CB-38BD7C2CC569
P2860
Alterations of choline phospholipid metabolism in ovarian tumor progression.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Alterations of choline phospholipid metabolism in ovarian tumor progression.
@en
type
label
Alterations of choline phospholipid metabolism in ovarian tumor progression.
@en
prefLabel
Alterations of choline phospholipid metabolism in ovarian tumor progression.
@en
P2093
P50
P1433
P1476
Alterations of choline phospholipid metabolism in ovarian tumor progression.
@en
P2093
Antonio Pavan
Carlo Ramoni
Danilo Millimaggi
Franca Podo
Paola Alberti
Sandra D'Ascenzo
Silvana Canevari
P304
P356
10.1158/0008-5472.CAN-05-1146
P407
P577
2005-10-01T00:00:00Z